ARCHIVES

Letrozole cuts risk of recurrent breast cancer in post-menopausal women.

This article is from The Cancer Letter archive.

Vol. 29 No. 38 | October 17, 2003

Download PDF Visit The Full Archive

Related Articles

Not All Women Benefitting From Less Invasive Staging

April 25, 2008

ODAC Rejects Amsacrine NDA, Renews Idarubicin

September 14, 1990

ASCO Is a Society In Transition, Growth; Major changes over Past Year

May 24, 1996

President Signs Interim Money Bill; NCI At $725 Million

July 4, 1975

I-ELCAP: NEJM And Other Journals Seek Information On The Study’s Confidential Review From Henschke And Her Employers

May 6, 2011

NCI Places Hold On Genentech Drug Trials, Citing Disagreement Over Intellectual Property Provisions.

March 12, 2010